A detailed history of Wade G W & Inc transactions in Novartis Ag stock. As of the latest transaction made, Wade G W & Inc holds 20,428 shares of NVS stock, worth $2.01 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,428
Previous 20,432 0.02%
Holding current value
$2.01 Million
Previous $2.08 Million 0.86%
% of portfolio
0.07%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

SELL
$92.27 - $101.54 $369 - $406
-4 Reduced 0.02%
20,428 $2.06 Million
Q3 2023

Nov 08, 2023

SELL
$94.73 - $105.13 $221,668 - $246,004
-2,340 Reduced 10.28%
20,432 $2.08 Million
Q2 2023

Aug 10, 2023

BUY
$92.52 - $104.91 $1.17 Million - $1.32 Million
12,604 Added 123.96%
22,772 $2.3 Million
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $7,842 - $9,095
-98 Reduced 0.95%
10,168 $935,000
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $69,203 - $84,748
-916 Reduced 8.19%
10,266 $931,000
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $2.02 Million - $2.36 Million
-27,094 Reduced 70.79%
11,182 $850,000
Q2 2022

Aug 09, 2022

BUY
$80.52 - $93.75 $2.03 Million - $2.36 Million
25,166 Added 191.96%
38,276 $3.24 Million
Q1 2022

May 10, 2022

BUY
$80.11 - $90.62 $10,334 - $11,689
129 Added 0.99%
13,110 $1.15 Million
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $162,189 - $179,344
2,035 Added 18.59%
12,981 $1.14 Million
Q3 2021

Nov 03, 2021

BUY
$81.78 - $95.14 $63,215 - $73,543
773 Added 7.6%
10,946 $895,000
Q2 2021

Aug 12, 2021

BUY
$85.24 - $94.15 $30,089 - $33,234
353 Added 3.59%
10,173 $928,000
Q1 2021

May 05, 2021

BUY
$83.5 - $98.47 $376,752 - $444,296
4,512 Added 85.0%
9,820 $839,000
Q4 2020

Feb 03, 2021

BUY
$78.07 - $94.43 $414,395 - $501,234
5,308 New
5,308 $501,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.